Rare Disease Stakeholders Worry About US FDA Shirking Adcomms

 
• By Derrick Gingery
  
Advocates worry about inconsistent FDA decision-making on rare disease applications. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from United States